戻る Agenda
Regulatory Affairs: Part 4: Adverse Events and Quality Assurance
Session Chair(s)
Drusilla Scott, PhD, RAC
Vice President, Regulatory Affairs
Sobi, Inc., United States
Regulatory Affairs: Part 4: Adverse Events and Quality Assurance
DIAアカウントをお持ちの場合、サインインしてください。
サインイン
Not a Member?
Hyatt Regency Bethesda
2020年3月23日 (月) 午前 9:00 - 2020年3月27日 (金) 午後 1:45
One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814-5326
Attend this virtual training course to learn about FDA regulations and expectations for the content, submission and review of INDs/NDAs, and the importance of regulatory strategy.
戻る Agenda
Vice President, Regulatory Affairs
Sobi, Inc., United States
Regulatory Affairs: Part 4: Adverse Events and Quality Assurance